Search

Your search keyword '"Mathisen, M.S."' showing total 6 results
Start Over Author "Mathisen, M.S."
6 results on '"Mathisen, M.S."'

1. 157TiP Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+ advanced non-small cell lung cancer (NSCLC)

Author

Skoulidis, F., primary, Cuppens, K., additional, Sacher, A., additional, Velcheti, V., additional, Lee, D.H., additional, Lin, M.T., additional, Fernando, T.M., additional, Li, S., additional, Bradley, D., additional, Crnkovic, M. Zarak, additional, and Mathisen, M.S., additional

Published
2023
Full Text
View/download PDF

2. 1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C

Author

Dziadziuszko, R., primary, Peters, S., additional, Gadgeel, S.M., additional, Mathisen, M.S., additional, Shagan, S.M., additional, Felip, E., additional, Morabito, A., additional, Cheema, P., additional, Dols, M. Cobo, additional, Andric, Z., additional, Barrios, C.H., additional, Yamaguchi, M., additional, Dansin, E., additional, Danchaivijitr, P., additional, Johnson, M., additional, Novello, S., additional, Gandara, D.R., additional, Schleifman, E., additional, Wang, J., additional, and Mok, T.S.K., additional

Published
2021
Full Text
View/download PDF

3. 1361P Alectinib for treatment-naïve advanced ALK+ NSCLC selected via blood-based NGS: Updated analyses of outcomes, circulating tumour (ct)DNA and biomarker subgroups from BFAST Cohort A

Author

Gadgeel, S.M., Mok, T.S.K., Peters, S., Nadal, E., Han, J-Y., Alatorre Alexander, J.A., Leighl, N., Sriuranpong, V., Pérol, M., Castro, G.D., de Marinis, F., Tan, D.S.W., Paul, S., Assaf, Z.J., MacLennan, M., Lohmann, T.O., Slade, M., Mathisen, M.S., Bhagawati-Prasad, V., and Dziadziuszko, R.

Published
2023
Full Text
View/download PDF

4. 1307P Blood-based genomic profiling of advanced non-small cell lung cancer (aNSCLC) patients (pts) from blood first assay screening trial (BFAST) and comparison with real-world data (RWD)

Author

Dziadziuszko, R., primary, Zhang, Q., additional, Li, X., additional, Paul, S.M., additional, Sugidono, M., additional, Mocci, S., additional, Kinkolykh, A., additional, Shames, D.S., additional, Archer, V., additional, Mathisen, M.S., additional, Jin, D.X., additional, Gadgeel, S.M., additional, Peters, S., additional, and Mok, T., additional

Published
2020
Full Text
View/download PDF

5. Phase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naïve NSCLC: Initial results from the ALK+ cohort

Author

Gadgeel, S.M., primary, Mok, T.S.K., additional, Peters, S., additional, Alexander, J.A.A., additional, Leighl, N.B., additional, Sriuranpong, V., additional, Perol, M., additional, De Castro, G., additional, Nadal, E., additional, De Marinis, F., additional, Han, J.-Y., additional, Yan, M., additional, Riehl, T., additional, Schleifman, E., additional, Paul, S.M., additional, Mocci, S., additional, Shames, D., additional, Mathisen, M.S., additional, and Dziadziuszko, R., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results